| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 833-847, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
F Hedborg, R Ohlsson, B Sandstedt, L Grimelius, JC Hoehner and S Pahlman
Department of Pathology, University Hospital, Uppsala, Sweden.
Neuroblastoma is a childhood tumor of the sympathetic nervous system. Observations in the Beckwith-Wiedemann syndrome suggest that sympathetic embryonal cells with an abundant expression of the insulin- like growth factor 2 gene (IGF2) may be involved in the genesis of low- malignant infant neuroblastomas. We have therefore compared the cell type-specific IGF2 expression of the human sympathetic nervous system during early development with that of neuroblastoma. An abundant expression in normal sympathetic tissue was specific to extra-adrenal chromaffin cells, ie, paraganglia and small intensely fluorescent (SIF) cells, whereas sympathetic neuronal cells were IGF2-negative. A subpopulation of neuroblastomas expressed IGF2, which correlated with an early age at diagnosis, an extra-adrenal tumor origin, and severe hemodynamic signs of catecholamine secretion. Histologically IGF2- expressing tumors displayed a lobular growth pattern, and expression was restricted to the most mature and least proliferative cells. Typically, these cells were morphologically and histochemically similar to paraganglia/SIF cells and formed distinct ring-like zones in the center of the lobules around a core of apoptosis-like tumor cells. The similarities found between IGF2-expressing neuroblastoma cells and paraganglia/SIF cells in terms of histological features, anatomical origin, and age-dependent growth suggest a paraganglionic/SIF cell lineage of most infant tumors and also of extra-adrenal tumors diagnosed after infancy. Furthermore, since paraganglia/SIF cells undergo postnatal involution, the same cellular mechanism may be responsible for spontaneous regression in infant neuroblastoma.
This article has been cited by other articles:
![]() |
F. HEDBORG, E. ULLERAS, L. GRIMELIUS, E. WASSBERG, P. H MAXWELL, B. HERO, F. BERTHOLD, F. SCHILLING, D. HARMS, B. SANDSTEDT, et al. Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma FASEB J, April 1, 2003; 17(6): 598 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Edsjö, B. Hallberg, S. Fagerström, C. Larsson, H. Axelson, and S. Påhlman Differences in Early and Late Responses between Neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y Neuroblastoma Cells Cell Growth Differ., January 1, 2001; 12(1): 39 - 50. [Abstract] [Full Text] |
||||
![]() |
C. J. Kim, T. Matsuo, K.-H. Lee, and C. J. Thiele Up-Regulation of Insulin-Like Growth Factor-II Expression Is a Feature of TrkA but Not TrkB Activation in SH-SY5Y Neuroblastoma Cells Am. J. Pathol., November 1, 1999; 155(5): 1661 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wassberg, F. Hedborg, E. Skoldenberg, M. Stridsberg, and R. Christofferson Inhibition of Angiogenesis Induces Chromaffin Differentiation and Apoptosis in Neuroblastoma Am. J. Pathol., February 1, 1999; 154(2): 395 - 403. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |